96661 ⎘
Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof
Sub-classes:COMPOSITIONS AND METHODS FOR PURIFYING ANTIGEN-BINDING ANTIBODY FRAGMENTS USING PEPTIDE LIGANDS
#2Oxyanion azide-benzaldehyde acetal acid-degradable lipids
#3SWITCHING PEPTIDE, IMMUNOASSAY DEVICE COMPRISING SAME, AND IMMUNOASSAY METHOD USING SAME
#4DE NOVO DESIGNED MACROCYCLIC OLIGOAMIDES
#5Methods and Compositions for Delivery of Biotin to Mitochondria
#6METHODS OF GENERATING POPULATIONS OF TUMOUR-INFILTRATING T CELLS
#7GLP-1/GIP DUAL AGONISTS
#8Compounds For Molecular Imaging of Collagen Turnover and Methods Using Same
#9PROGRAMMABLE CAS9-RECOMBINASE FUSION PROTEINS AND USES THEREOF
#10PROCOAGULANT PEPTIDES AND USE THEREOF
#11SAP AND PEPTIDOMIMETICS FOR TREATMENT OF EYE DISEASE
#12CHIMERIC POLYPEPTIDES AND USES THEREOF
#13BETA-STRAND BRIDGE PEPTIDE
#14COMPOSITIONS HAVING THIOREDOXIN ACTIVITY AND RELATED METHODS
#15METHOD FOR MANUFACTURING MONOCLONAL ANTIBODY USING YEAST, AND SCREENING METHOD
#16Agents modulating beta-catenin functions and methods thereof
#17Methods for Treating Breast Cancer and for Identifying Breast Cancer Antigens
#18Heteroaryl sulfone-based conjugation handles, methods for their preparation, and their use in synthesizing antibody drug conjugates
#19Composition and Methods of Controllable Co-Coupling Polypeptide Nanoparticle Delivery System for Nucleic Acid Therapeutics
#20PEPTIDE TAG AND TAGGED PROTEIN INCLUDING SAME
#21Peptides with anti-cancer activity
#22Chimeric polypeptides and uses thereof
#23Agents modulating beta-catenin functions and methods thereof
#24Antimicrobial peptides and compositions, methods, articles and kits relating thereto
#25Peptides and methods and uses thereof for modulating anaphase promoting complex (APC) activity
#26Modified lipopolysaccharide glycoform and method of use
#27NUCLEOSIDES WITH ANTIVIRAL AND ANTICANCER ACTIVITY
#28PEPTIDE-BASED VACCINES, METHODS OF MANUFACTURING, AND USES THEREOF FOR INDUCING AN IMMUNE RESPONSE
#29Methods of designing novel antibody mimetics for use in detecting antigens and as therapeutic agents
#30Programmable CAS9-recombinase fusion proteins and uses thereof
#31Prodrugs of Chlorokynurenines
#32SAP AND PEPTIDOMIMETICS FOR TREATMENT OF EYE DISEASE
#33Detection and treatment of demyelinating diseases
#34Opioid receptor modulators
#35CHIMERIC POLYPEPTIDES AND USES THEREOF
#36Peptides with anti-cancer activity
#37METHODS OF GENERATING POPULATIONS OF TUMOUR-INFILTRATING T CELLS
#38Peptide tag and tagged protein including same
#39Dipeptide comprising a non-proteogenic amino acid
#40Methods for treating breast cancer and for identifying breast cancer antigens
#41PRODRUGS OF CHLOROKYNURENINES
#42NUCLEOSIDES WITH ANTIVIRAL AND ANTICANCER ACTIVITY
#43CATIONIC PEPTIDOPOLYSACCHARIDES WITH EXCELLENT BROAD- SPECTRUM ANTIMICROBIAL ACTIVITIES AND HIGH SELECTIVITY
#44Methods for Chemical Synthesis of Biologically Active Compounds Using Supramolecular Protective Groups and Novel Compounds Obtainable Thereby
#45Alphaa-crystallin mimetic peptides and uses thereof
#46Bis-alkoxyl amide alkyl cationic peptide lipids, synthesis method thereof, and application thereof
#47PEPTIDES BASED ON THE TRANSMEMBRANE DOMAIN OF A TOLL-LIKE RECEPTOR (TLR) FOR TREATMENT OF TLR-MEDIATED DISEASES
#48Potassium channel blockers and use thereof in the treatment of autoimmune diseases
#49SKIN PENETRATING PEPTIDES (SPPS) AND METHODS OF USE THEREFOR
#50METHODS FOR PRENYLATION OF PEPTIDES AND THEIR USE IN OVER-PRODUCTION OF FARNESENE AND GERANYLGERANYL TERPENES
#51Modified lipopolysaccharide glycoform and method of use
#52Triazole macrocycle systems
#53Crosslinking reagents, methods, and compositions for studying protein-protein interactions
#54Amyloidosis-inhibiting polypeptides and their use
#55Fusion protein comprising granzyme B and use thereof
#56Modified lipopolysaccharide glycoform and method of use
#57Molecular sleds and uses thereof
#58Crystals of semiconductor material having a tuned band gap energy and method for preparation thereof
#59NUCLEOSIDES WITH ANTIVIRAL AND ANTICANCER ACTIVITY
#60Dipeptide Comprising a Non-Proteogenic Amino Acid
#61NOVEL A4B7 PEPTIDE DIMER ANTAGONISTS
#62TRANSCUTANEOUS DELIVERY OF THERAPEUTIC AGENTS
#63Peptide derivatives and use thereof as carriers for molecules in the form of conjugates
#64CATIONIC PEPTIDOPOLYSACCHARIDES WITH EXCELLENT BROAD- SPECTRUM ANTIMICROBIAL ACTIVITIES AND HIGH SELECTIVITY
#65RNA targeting compounds and methods for making and using same
#66Inhibitors of viral integrase and methods of use
#67Therapeutic peptides
#68Peptides based on the transmembrane domain of a toll-like receptor (TLR) for treatment of TLR-mediated diseases
#69Proteolytically resistant hydrogen bond surrogate helices
#70CROSSLINKING REAGENTS, METHODS, AND COMPOSITIONS FOR STUDYING PROTEIN-PROTEIN INTERACTIONS
#71Compounds and methods for purifying peptides produced by solid phase peptide synthesis
#72Probe incorporation mediated by enzymes
#73Triazole macrocycle systems
#74Inhibitors of viral integrase and methods of use
#75Triazole macrocycle systems
#76Peptides
#77Peptide derivatives and use thereof as carriers for molecules in the form of conjugates
#78Transcutaneous delivery of therapeutic agents
#79Activating peptide of the synthesis of aquaporins and cosmetic and/or pharmaceutical composition containing it
#80Nucleosides with antiviral and anticancer activity
#81Methods and compositions for protein labeling using lipoic acid ligases
#82Immunoregulatory compositions
#83Triazole macrocycle systems
#84RNA targeting compounds and methods for making and using same
#85Synthetic peptides and methods of use for autoimmune disease therapies
#86IMMUNOREGULATORY COMPOSITIONS
#87Self-assembling amphiphilic peptides